Literature DB >> 34031606

Putting the MD back into MDMA.

David J Nutt1, Harriet de Wit2.   

Abstract

Entities:  

Year:  2021        PMID： 34031606     DOI： 10.1038/s41591-021-01385-8

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  8 in total

1.  The origin of MDMA (ecstasy) revisited: the true story reconstructed from the original documents.

Authors:  Roland W Freudenmann; Florian Oxler; Sabine Bernschneider-Reif
Journal:  Addiction       Date:  2006-09       Impact factor: 6.526

Review 2.  MDMA-assisted psychotherapy for PTSD: Are memory reconsolidation and fear extinction underlying mechanisms?

Authors:  Allison A Feduccia; Michael C Mithoefer
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2018-03-07       Impact factor: 5.067

3.  MDMA enhances emotional empathy and prosocial behavior.

Authors:  Cédric M Hysek; Yasmin Schmid; Linda D Simmler; Gregor Domes; Markus Heinrichs; Christoph Eisenegger; Katrin H Preller; Boris B Quednow; Matthias E Liechti
Journal:  Soc Cogn Affect Neurosci       Date:  2013-10-04       Impact factor: 3.436

4.  First study of safety and tolerability of 3,4-methylenedioxymethamphetamine-assisted psychotherapy in patients with alcohol use disorder.

Authors:  Ben Sessa; Laurie Higbed; Steve O'Brien; Claire Durant; Chloe Sakal; Daniel Titheradge; Tim M Williams; Anna Rose-Morris; Elsa Brew-Girard; Sam Burrows; Chantelle Wiseman; Sue Wilson; James Rickard; David J Nutt
Journal:  J Psychopharmacol       Date:  2021-02-18       Impact factor: 4.153

5.  The safety and efficacy of {+/-}3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study.

Authors:  Michael C Mithoefer; Mark T Wagner; Ann T Mithoefer; Lisa Jerome; Rick Doblin
Journal:  J Psychopharmacol       Date:  2010-07-19       Impact factor: 4.153

6.  Oxytocin-dependent reopening of a social reward learning critical period with MDMA.

Authors:  Romain Nardou; Eastman M Lewis; Rebecca Rothhaas; Ran Xu; Aimei Yang; Edward Boyden; Gül Dölen
Journal:  Nature       Date:  2019-04-03       Impact factor: 69.504

7.  MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study.

Authors:  Jennifer M Mitchell; Michael Bogenschutz; Alia Lilienstein; Charlotte Harrison; Sarah Kleiman; Kelly Parker-Guilbert; Marcela Ot'alora G; Wael Garas; Casey Paleos; Ingmar Gorman; Christopher Nicholas; Michael Mithoefer; Shannon Carlin; Bruce Poulter; Ann Mithoefer; Sylvestre Quevedo; Gregory Wells; Sukhpreet S Klaire; Bessel van der Kolk; Keren Tzarfaty; Revital Amiaz; Ray Worthy; Scott Shannon; Joshua D Woolley; Cole Marta; Yevgeniy Gelfand; Emma Hapke; Simon Amar; Yair Wallach; Randall Brown; Scott Hamilton; Julie B Wang; Allison Coker; Rebecca Matthews; Alberdina de Boer; Berra Yazar-Klosinski; Amy Emerson; Rick Doblin
Journal:  Nat Med       Date:  2021-05-10       Impact factor: 53.440

8.  The Effects of Acutely Administered 3,4-Methylenedioxymethamphetamine on Spontaneous Brain Function in Healthy Volunteers Measured with Arterial Spin Labeling and Blood Oxygen Level-Dependent Resting State Functional Connectivity.

Authors:  Robin L Carhart-Harris; Kevin Murphy; Robert Leech; David Erritzoe; Matthew B Wall; Bart Ferguson; Luke T J Williams; Leor Roseman; Stefan Brugger; Ineke De Meer; Mark Tanner; Robin Tyacke; Kim Wolff; Ajun Sethi; Michael A P Bloomfield; Tim M Williams; Mark Bolstridge; Lorna Stewart; Celia Morgan; Rexford D Newbould; Amanda Feilding; H Val Curran; David J Nutt
Journal:  Biol Psychiatry       Date:  2014-01-10       Impact factor: 13.382
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.